Skip to main content
. 2021 May 29;21:633. doi: 10.1186/s12885-021-08382-7

Table 2.

Malignancy underestimation rates of B3 subtypes

B3 subtype Number Underestimation Rate (%)
ADH 13 3 23.1
FEA 4 0 0
LN 3 0 0
PL 84 2 2.4
PL/ADH 2 1 50
PT 71 1 1.4
CSL/RS 6 1 16.7

ADH atypical ductal hyperplasia, FEA flat epithelial atypia, LN classical lobular neoplasia, PL papillary lesions, PL/ADH papillary lesions/atypical ductal hyperplasia, PT phyllodes tumors, CSL/RS complex sclerosing lesions/radial scars